首页> 外国专利> METHOD OF TREATING RESISTANT NON-HODGKIN LYMPHOMA, MEDULLOBLASTOMA, AND/OR ALK+NON-SMALL CELL LUNG CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS.

METHOD OF TREATING RESISTANT NON-HODGKIN LYMPHOMA, MEDULLOBLASTOMA, AND/OR ALK+NON-SMALL CELL LUNG CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS.

机译:硫代三唑并二氮杂化合物治疗抗非霍奇金淋巴瘤,髓母细胞瘤和/或ALK +非小细胞肺癌的方法。

摘要

A method of treating resistant non-Hodgkin lymphoma, medulloblastoma, and/or ALK+ non-small cell lung cancer in a mammal by administering ajsolid dispersion comprising an amorphous thienotriazolodiazepine compound of the Formula (1) wherein R' is alkyl having a carbon number of 1-4, R2 is a hydrogen atom; a halogen atom; or alkyl having a carbon number of 1-4 optionally substituted by a halogen atom or a hydroxyl group, R3 is a halogen atom; phenyl optionally substituted by a halogen atom, alkyl having a carbon number of 1-4, alkoxy having a carbon number of 1-4 or cyano; -NR 5 -{CH 2)m-,-R6 wherein R5 is a hydrogen atom or alkyl having a carbon number of 1-4, m is an integer of 0-4, and R6 is phenyl or pyridyl optionally substituted by a halogen atom.
机译:一种通过给药包含式(1)的无定形硫杂氮杂氮杂二氮杂卓化合物的固体分散体来治疗哺乳动物中的耐药性非霍奇金淋巴瘤,髓母细胞瘤和/或ALK +非小细胞肺癌的方法,其中R'是碳数为1的烷基。 1-4,R 2是氢原子;卤素原子; R 3为卤素原子;或碳原子数为1〜4的烷基,可任选地被卤素原子或羟基取代。任选地被卤素原子取代的苯基,碳数为1-4的烷基,碳数为1-4的烷氧基或氰基; -NR 5-{CH 2)m-,-R6其中R5是氢原子或碳数为1-4的烷基,m是0-4的整数,R6是任选地被卤素取代的苯基或吡啶基原子。

著录项

  • 公开/公告号MX2016014299A

    专利类型

  • 公开/公告日2017-01-27

    原文格式PDF

  • 申请/专利权人 ONCOETHIX GMBH;

    申请/专利号MX20160014299

  • 发明设计人 KAY NOEL;

    申请日2015-05-01

  • 分类号A61K31/5517;

  • 国家 MX

  • 入库时间 2022-08-21 13:37:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号